{"id":"W4403537585","doi":"10.1016/j.esmoop.2024.103818","title":"77P Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Medical Research Council; Genentech; Sierra Oncology; Astellas Pharma; Eisai; Prostate Cancer UK; Cancer Research UK; National Center for Advancing Translational Sciences; Wellcome Trust; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Movember Foundation; Daiichi Sankyo Europe; U.S. Department of Defense; Sanofi; Amgen; Pfizer; Vertex Pharmaceuticals; National Institutes of Health; Menarini Silicon Biosystems","keywords":"Prostate cancer; MCL1; Cancer; Medicine; Prostate; Cancer research; Internal medicine; Biology; Genetics; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002762179,0.0003607826,0.0003817147,0.0004819836,0.0002355175,0.000638094,0.0004021109,0.0002912004,0.005740582],"category_scores_gemma":[0.0002032879,0.0001382932,0.0002708237,0.0002477707,0.0003572847,0.0006145115,0.0003964875,0.0009148612,0.0008313301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004929197,"about_ca_system_score_gemma":0.0007601231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007919446,"about_ca_topic_score_gemma":0.002108255,"domain_scores_codex":[0.9999076,0.00001243737,0.000004600973,0.00001294008,0.00003087818,0.00003153862],"domain_scores_gemma":[0.9999512,0.000007262006,0.00001239701,0.000004654266,0.000008478024,0.00001597964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001444227,0.001109965,0.001150678,0.001301289,0.0001032156,0.0005345145,0.0000955916,0.003295031,0.6904117,0.01241932,0.008304105,0.2798304],"study_design_scores_gemma":[0.001000527,0.0116981,0.009689289,0.000294426,0.0004346809,0.003357158,0.0002467728,0.01122403,0.7101314,0.006920015,0.2449155,0.00008810704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7425117,0.1536221,0.0289912,0.009098405,0.001090371,0.0007302315,0.001673696,0.0007108693,0.06157134],"genre_scores_gemma":[0.925009,0.04749679,0.01069083,0.001164641,0.0002081915,0.0002601285,0.000691736,0.00006620109,0.01441242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005740582,"threshold_uncertainty_score":0.01920414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0645400951627398,"score_gpt":0.3920523083365812,"score_spread":0.3275122131738414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}